Acute coronary syndrome and stable coronary artery disease: Are they so different? Long-term outcomes in a contemporary PCI cohort

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1343-1346

  Alcock, R F ^a   Yong, A S C ^a   Ng, A C C ^a   Chow, V ^a   Cheruvu, C ^a   Aliprandi Costa, B ^a   Lowe, H C ^a   Kritharides, L ^a   Brieger, D B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acute coronary syndrome; Percutaneous coronary intervention; Stable coronary artery disease

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HEART MUSCLE INJURY; HOSPITAL DISCHARGE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TERTIARY HEALTH CARE; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; STABLE CORONARY ARTERY DISEASE;

ACUTE CORONARY SYNDROME; AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881475708     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.011     Document Type: Article

References (31)

1. W. Boden, R. O'Rourke, and K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
2. R. Henderson, S. Pocock, and T. Clayton Second Randomized Intervention Treatment of Angina (RITA-2) trial participants. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy J Am Coll Cardiol 42 2003 1161 1170
3. W. Hueb, N. Lopes, and B. Gersh Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 115 2007 1082 1089
4. D. Katritsis, and J. Ioannidis Percutaneous coronary intervention versus conservative therapy in non acute coronary artery disease: a meta-analysis Circulation 111 2005 2906 2912
5. C.W. Hamm, J. Ravkilde, and W. Gerhardt The prognostic value of serum troponin T in unstable angina N Engl J Med 327 1997 146 150
6. K. Fox, T. Clayton, and P. Damman Long-term outcome of a routine versus selective invasive strategy in patients with non-ST segment elevation acute coronary syndrome J Am Coll Cardiol 55 2010 2435 2445
7. F. Spencer, J. Allegrone, and R. Goldberg Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study Ann Intern Med 140 2004 857 866
8. K. Fox, S. Goodman, and W. Klein Management of acute coronary syndromes. Variations in practice and outcome Eur Heart J 23 2002 1177 1189
9. G. Montalescot, J. Dallongeville, and E. Van Belle STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition Eur Heart J 28 2007 1409 1417
10. Fast Revascularisation during In Stability in Coronary artery disease (FRISC II) Investigators Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study Lancet 360 1999 743 751
11. P. Christopher, C. Cannon, and W. Weintraub Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
12. D. Chew, J. Amerena, and S. Coverdale Invasive management provision and late clinical outcomes within contemporary Australian acute coronary syndrome management: observations from the ACACIA registry Med J Aust 188 2008 691 696
13. S. Mehta, C. Cannon, and Keith Fox Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials J Am Med Assoc 293 2005 2908 2917
14. S. Solomon, N. Anavekar, and H. Skali Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients Circulation 112 2005 3738 3744
15. E. Antman, M. Cohen, and P. Bernink The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision-making J Am Med Assoc 248 2000 835 842
16. A. Tonkin, P. Aylward, and D. Colquhoun Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1358
17. The Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
18. The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease Lancet 362 2003 782 788
19. ACE Inhibitor Myocardial Infarction Collaborative Group Indications for ACE inhibitors in the early treatment of acute myocardial infarction Circulation 97 1998 2202 2212
20. The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
21. D. Weiner, H. Tighiouart, and M. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315
22. J.F. Mann, H.C. Gerstein, J. Pogue, J. Bosch, and S. Yusuf Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
23. R.S. Wright, G.S. Reeder, and C.A. Herzog Acute myocardial infarction and renal dysfunction: a high-risk combination Ann Intern Med 137 2002 563 570
24. M.G. Shlipak, P.A. Heidenreich, H. Noguchi, G.M. Chertow, W.S. Browner, and M.B. McClellan Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients Ann Intern Med 137 2002 555 562
25. M.G. Shlipak, J.A. Simon, D. Grady, F. Lin, N.K. Wenger, and C.D. Furberg Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease J Am Coll Cardiol 38 2001 705 711
26. D. Blackman, R. Pinto, and J. Ross Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention Am Heart J 151 2006 146 152
27. P.J. Best, R. Lennon, and H.H. Ting The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119
28. L. Gruberg, N. Weissman, and R. Waksman Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency Am J Cardiol 89 2002 54 57
29. S. Naidu, F. Selzer, and A. Jacobs Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention Am J Cardiol 92 2003 1160 1164
30. K. Fox, K. Carruthers, and D. Dunbar Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study) Eur Heart J 31 2010 2755 2764
31. K. Fox, O. Dabbous, and R. Goldberg Prediction of risk of death and myocardial infarction in the first six months following presentation with ACS: a prospective, multinational, observational study (GRACE) BMJ 333 2006 1091 1094